Glenmark Pharmaceuticals Ltd Quarterly Results

Gross Sales

3,220.13

3,301.9

3,400.5

3,223.3

3,016.01

Excise Duty

0

0

0

0

0

Net Sales

3,220.13

3,301.9

3,400.5

3,223.3

3,016.01

Other Operating Income

36.07

85.65

33.3

20.88

46.95

Other Income

11.69

31.13

39.42

31.49

797.54

Total Income

3,267.89

3,418.68

3,473.21

3,275.68

3,860.49

Total Expenditure

3,068

2,787.32

2,831.88

2,655.97

3,005.39

PBIDT

199.89

631.36

641.33

619.71

855.1

Interest

66.71

52.29

48.48

39.58

148.56

PBDT

133.18

579.06

592.85

580.12

706.54

Depreciation

125.21

122.74

120.28

117.79

151.34

Minority Interest Before NP

0

0

0

0

0

Tax

-3.5

103.05

135.91

146.88

1,058.17

Deferred Tax

7.09

5.24

-17.82

-24.79

711.3

Reported Profit After Tax

4.38

348.03

354.49

340.24

-1,214.27

Minority Interest After NP

-0.27

0.07

0.27

-0.03

4.01

Net Profit after Minority Interest

4.65

347.96

354.21

340.27

-1,218.28

Extra-ordinary Items

-365.73

0

0

0

1,066.92

Adjusted Profit After Extra-ordinary item

370.38

347.96

354.21

340.27

-2,285.2

EPS (Unit Curr.)

0.16

12.33

12.55

12.06

-43.17

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

28.22

28.22

28.22

28.22

28.22

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

6.2

19.12

18.85

19.22

28.35

PBDTM(%)

4.13

17.53

17.43

17.99

23.42

PATM(%)

0.13

10.54

10.42

10.55

-40.26